This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02350/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02350/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02350/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02350/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02350/identifier/drugbank/

Statements

Subject Item
n2:DB02350
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02350 n14:DB02350
dcterms:title
N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide
adms:identifier
n9:DB02350 n10:MM3 n11:4450896 n12:5288814 n13:46506272
n3:IUPAC-Name
n4:271B5561-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5567-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5566-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5563-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5564-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5565-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B555F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B555D-363D-11E5-9242-09173F13E4C5 n4:271B5560-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B555E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B556D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B556E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5568-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5569-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B556B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B556A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B556C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5573-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5575-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5576-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5572-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5571-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5574-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5562-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B556F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5570-363D-11E5-9242-09173F13E4C5